Prescription patterns and quality of medications for individuals with migraine were similar among racial groups. The study was based on patient data from the National Ambulatory Medical Care Survey and published in Cephalalgia.
Researchers reviewed more than 2,800 patient visits between 2006 and 2013 and found no differences among racial groups who did not receive prophylactic treatments.
The study found no differences between patient groups not receiving abortive treatments. Level A abortives, such as triptans and dihydroergotamine, were prescribed to 15.3% of African American patients, 19.4% non-Hispanic White patients, and 17.7% Hispanic patients.
About 15.2% of all patients received opiate prescriptions and no racial differences were found.
Researchers found that opiate medications may be overused in individuals with migraine, regardless of their racial group. They also noted that Level A acute analgesics were underused. They said their data show that there is an opportunity to improve medication prescribing quality for all patients.
Many individuals with migraine or another headache disease seek complementary or alternative treatments to medication. Some complementary or alternative treatments, such as acupuncture and mind-body therapies, have shown promising results in clinical trials. With the popularity of these treatments, a group of researchers looked to learn more about which treatments were most preferred by individuals with migraine or other headache diseases, as well as the reasons for selecting these alternative treatments. Continue Reading
Teaching children about invisible pain—whether it be their own pain or the pain of someone in their lives—can be a difficult task. Author Judith Klausner and illustrator Sarah Gould tried to shed some light on migraine and chronic pain with their children’s book Noah the Narwhal: A Tale of Downs and Ups.Continue Reading
Many patients diagnosed with migraine must also endure painful sensitivity to light during attacks, but a new report suggests that light is also a prominent trigger that must be taken into account.
TheraSpecs® Company surveyed 385 people with light sensitivity, 293 of which also reported having migraine, and discovered that 88% of migraine respondents cited light as a direct catalyst for their attacks. Existing clinical data has previously suggested that light is a trigger for perhaps as many as 60% of patients.1Continue Reading